Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: An apparatus comprises: a first integrated circuit comprising: a plurality of sets of optical waveguides, each set of optical waveguides including a plurality of optical waveguide segments, and a plurality of optical emitter elements arranged over a first surface of the first integrated circuit, each optical emitter element coupled to a distal end of one of the optical waveguide segments; and a second integrated circuit comprising: a plurality of optical phase shifters that each provide a phase-shifted optical wave that is coupled to the first integrated circuit from a first edge surface of the second integrated circuit. The first edge surface of the second integrated circuit is in proximity to a row of proximal ends of the optical waveguide segments of a first set of the plurality of sets of optical waveguides.

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: A method for synthesizing speech from a textual input includes receiving the textual input, the textual input including native words in a native language and foreign words in a foreign language, and processing the textual input to determine a phonetic representation of the textual input. The processing includes determining a native phonetic representation of the of the native words, and determining a nativized phonetic representation of the foreign words. Determining the nativized phonetic representation includes forming a foreign phonetic representation of the foreign words using a foreign phoneme set, and mapping the foreign phonetic representation to the nativized phonetic representation according to a model of a native speaker's pronunciation of foreign words.

Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.

Abstract: A six transistor SRAM memory cell design is discussed. An SRAM memory cell includes criss-crossed transistors in cross-coupled inverters to achieve a more compact form factor and simplify fabrication.

Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: A six transistor SRAM memory cell design is discussed. An SRAM memory cell includes criss-crossed transistors in cross-coupled inverters to achieve a more compact form factor and simplify fabrication.

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: Described technologies enhance cybersecurity and facilitate computing system account usage by configuring a primary account and a supplementary account together in a security configuration lifecycle. The primary account user may be a parent or other adult, while the supplementary account user may be a child or other person with less capacity than the primary user. Over time, the accounts may transition together through security configurations to give more capabilities to the supplementary user, e.g., login separate from the primary user, and to reduce the control of the primary user over the supplementary account. Security configuration lifecycle stages are implemented, e.g., using capability-security pair data structures and account security configuration code. Despite the security configuration linkage of the accounts, each account may have its own personalized content and its own recommendation history.

Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.

Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: Described technologies enhance cybersecurity and facilitate computing system account usage by configuring a primary account and a supplementary account together in a security configuration lifecycle. The primary account user may be a parent or other adult, while the supplementary account user may be a child or other person with less capacity than the primary user. Over time, the accounts may transition together through security configurations to give more capabilities to the supplementary user, e.g., login separate from the primary user, and to reduce the control of the primary user over the supplementary account. Security configuration lifecycle stages are implemented, e.g., using capability-security pair data structures and account security configuration code. Despite the security configuration linkage of the accounts, each account may have its own personalized content and its own recommendation history.

Abstract: According to some embodiments, a tie-bolt support assembly is provided which includes a support spring for engagement with both the tie-bolt and a rotor assembly to maintain a load path between the tie-bolt and the rotor assembly while also allowing for axial movement of the tie-bolt.

Abstract: Disclosed are methods and mask structures for epitaxially growing substantially defect-free semiconductor material. In some embodiments, mask structure includes a first level defining a first trench extending through the first level, wherein a bottom of the first trench is defined by a semiconductor substrate, and a second level on top of the first level, wherein the second level defines a plurality of second trenches positioned at a non-zero angle with respect to the first trench.

Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Abstract: Methods and systems determining customer satisfaction in a work environment via prescriptive analytics. Self-reported data related to the perception of an agent with respect to customer satisfaction in a work environment (e.g., a call center) can be collected via an interface (e.g., an agent dashboard) that allows the agent to enter the self-reported data regarding the customer satisfaction. The self-reported data can then be correlated with an actual customer satisfaction score associated with the agent to derive data indicative of an interaction between the agent and a customer(s). Feedback data can then be provided via the interface indicating a correctness of the self-reported data based on correlating the self-reported data with the actual customer satisfaction score.

Abstract: The present invention provides novel compounds (e.g., compounds of Formula (I)), and pharmaceutically acceptable salts, solvates, hydrate, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits comprising the inventive Compounds, or compositions thereof, for treating and/or preventing a fungal or protozoan infection, inhibiting the activity of a fungal or protozoan enzyme, killing a fungus or protozoan, or inhibiting the growth of a fungus or protozoan. The fungus may be a Candida species, Sacchawmyces species, or other pathogenic fungal species. The compounds of the invention may inhibit the activity of fungal or protozoan mitochondrial phosphate carrier protein.

Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.

Abstract: Techniques and mechanisms for providing efficient direction of light to a photodetector with a tapered waveguide structure. In an embodiment, a taper structure of a semiconductor device comprises a substantially single crystalline silicon. A buried oxide underlies and adjoins the monocrystalline silicon of the taper structure, and a polycrystalline Si is disposed under the buried oxide. During operation of the semiconductor device light is redirected in the taper structure and received via a first side of a Germanium photodetector. In another embodiment, one or more mirror structures positioned on a far side of the Germanium photodetector may provide for a portion of the light to be reflected back to the Germanium photodetector.